Opinion

How the links of the supply chain are fighting to preserve quality service, even against factors that may be out of their hands.

October's issue continues its dedicated coverage surrounding the cold chain.

A reflection on my time with Pharma Commerce thus far, and a plan of action for moving the brand forward.

A look into ways to approach change management using three factors.

How drugmakers can navigate the program’s pricing challenges and regulatory developments.

Shift focus in orphan and ultra-orphan messaging to clinical benefit.

The August issue varies in subject matters, from the outlook for drug wholesaling to the value of a user-centric approach for drug adherence.

As Pharma Commerce continues to increase its conference exposure, it all could not have been possible without the help of colleagues.

The importance of industry, as it moves forward, in focusing on patient-centered care and prioritizing patient needs across the supply chain.

Micah Litow, Kalderos’ president and COO, discusses the importance of identifying and resolving noncompliant discount requests, along with addressing the gross-to-net gap for drug manufacturers.

The legislation’s deadline for compliance is knocking on the door. Pharma Commerce offers a synopsis of how the Drug Supply Chain Security Act has progressed over the past decade.

The publication's June installment features a plethora of coverage, ranging from the learning curve in digital adoption to an overview of the CVD market.

As the brand looks to increase its coverage, Pharma Commerce welcomes a pair of editorial contributors to the team.

Although there is no ‘one size fits all’ solution, the process is influenced by factors such as lifestyle stage, competitive outlook, and market constraints.

DSCSA, 340B among the headliners at the Healthcare Distribution Alliance's Distribution Management Conference.

How molding these elements into one can add efficiencies to work processes.

Why automation-enabling tech—such as NLP and ML—can help improve medicine effectiveness.

Senate committee report highlights a lack of visibility in API suppliers.

Pharma Commerce provides a look into a few of the conference’s highlights.

Event—taking place in Indianapolis—places supply chain education at the forefront.

A multitude of conclusions surrounding distribution were reached at the Trade & Channels Strategies conference.

Observations from recent digital health events and a glimpse of what’s ahead—from Milan to Boca Raton

Companies along the pharma value chain strive for carbon neutrality

How artificial intelligence is improving the patient experience

Product commercialization in Canada is by no means simple, but the end result presents its advantages

Decision-making technologies come to the forefront of the AI space

How pharma can speed up the journey with direct-to-patient models

Pharma Commerce's podcasts offer new angles on its roster of key topics

Given the biopharma sector‘s complex set of networks and supply chains, so it is not straightforward to shift towards net zero across all operations.

Dr. Frank Doyle, Dean of the Paulson School of Engineering and Applied Sciences at Harvard University, outlines his recommendations for Fortune 500 c-suites as they strive to attract, develop, and retain the best talent for their upcoming 2023 strategic plans.